Traitements du syndrome néphrotique cortico-dépendant de l’enfant
| Autor: | J. Hogan, Etienne Bérard, I. Vrillon, Anne Couderc, Claire Dossier, Vincent Audard, Véronique Baudouin, Vincent Guigonis, Olivia Boyer |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Cytopenia Cyclophosphamide business.industry 030232 urology & nephrology 030204 cardiovascular system & hematology medicine.disease Gastroenterology Tacrolimus Calcineurin 03 medical and health sciences 0302 clinical medicine Internal medicine Pediatrics Perinatology and Child Health Medicine Rituximab Hypoalbuminemia business Nephrotic syndrome medicine.drug Kidney disease |
| Zdroj: | Archives de Pédiatrie. 24:1312-1320 |
| ISSN: | 0929-693X |
| Popis: | Primary nephrotic syndrome (NS) is the most common glomerular disease in children. It is characterized by massive proteinuria and hypoalbuminemia. It typically has a sudden onset and more than 70% of patients will experience at least one relapse. An immunological origin has long been postulated, although the precise molecular mechanisms underlying the disease remain debated. Steroids are the first-line therapy with cumulative dose and duration of initial treatment varying among countries. Steroid-sparing agents may be indicated in case of steroid-dependency or frequent relapses. However, no consensus exists regarding the different treatment options. These treatments are mostly suspensive and therefore, need to be prolonged for several months. Levamisole, an antihelminthic drug, also has an immunomodulatory function, and alone or in combination with steroids, it can decrease cumulative steroid dose and relapses. It is usually well tolerated, and its principal side effects are cytopenia and elevated liver enzymes. Mycophenolate mofetil is an immunosuppressive agent whose reported side effects are cytopenia and diarrhea. Calcineurin inhibitors (cyclosporine or tacrolimus) have long been used in steroid-dependent patients. Their major side effects are hirsutism, gum hypertrophy, and nephrotoxicity, leading to interstitial kidney fibrosis and chronic kidney disease. Cyclophosphamide is an efficient treatment but its gonadal toxicity is a major drawback to its use. More recent drugs such as rituximab are very effective but require hospitalization for the infusion and induce an increased risk of opportunistic infection, prolonged neutropenia, and anaphylaxis. In this review, we present the available treatments, their indications, and the side effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect